Drugs that contain Minocycline Hydrochloride

1. Drug name - AMZEEQ

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10213512 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US10137200 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct, 2030

(7 years from now)

US8865139 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US9675700 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US8992896 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US10086080 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US10517882 JOURNEY Method for healing of an infected acne lesion without scarring Oct, 2030

(7 years from now)

US10821187 JOURNEY Compositions, gels and foams with rheology modulators and uses thereof Oct, 2030

(7 years from now)

US10265404 JOURNEY Compositions, gels and foams with rheology modulators and uses thereof Oct, 2030

(7 years from now)

US8945516 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct, 2030

(7 years from now)

US10849847 JOURNEY Compositions and methods for treating rosacea and acne Sep, 2037

(14 years from now)

US10398641 JOURNEY Compositions and methods for treating rosacea and acne Sep, 2037

(14 years from now)

Treatment: Treatment of non-nodular acne vulgaris

Dosage: AEROSOL, FOAM;TOPICAL

More Information on Dosage
Strength Dosage Availability
EQ 4% BASE AEROSOL, FOAM;TOPICAL Prescription

2. Drug name - MINOCIN

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9084802 REMPEX Tetracycline compositions May, 2031

(8 years from now)

US9278105 REMPEX Tetracycline compositions May, 2031

(8 years from now)

Treatment: Method of treating bacterial infections

Dosage: INJECTABLE;INJECTION

More Information on Dosage
Strength Dosage Availability
EQ 100MG BASE/VIAL INJECTABLE;INJECTION Prescription

3. Drug name - MINOLIRA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11103517 EPI HLTH Pharmaceutical compositions for minocycline Apr, 2036

(13 years from now)

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 105MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription
EQ 135MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription

4. Drug name - SOLODYN

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8252776 BAUSCH Minocycline oral dosage forms for the treatment of acne Jun, 2025

(2 years from now)

US8268804 BAUSCH Minocycline oral dosage forms for the treatment of acne Jun, 2025

(2 years from now)

US7790705 BAUSCH Minocycline oral dosage forms for the treatment of acne Jun, 2025

(2 years from now)

US8722650 BAUSCH Extended-release minocycline dosage forms Jun, 2025

(2 years from now)

US7919483 BAUSCH Method for the treatment of acne Mar, 2027

(4 years from now)

US7544373 BAUSCH Minocycline oral dosage forms for the treatment of acne Apr, 2027

(4 years from now)

US7541347 BAUSCH Minocycline oral dosage forms for the treatment of acne Apr, 2027

(4 years from now)

US9192615 BAUSCH Method for the treatment of acne and certain dosage forms thereof Nov, 2031

(9 years from now)

Treatment: Treatment of acne; Treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 45MG BASE TABLET, EXTENDED RELEASE;ORAL Discontinued
EQ 55MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription
EQ 65MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription
EQ 80MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription
EQ 90MG BASE TABLET, EXTENDED RELEASE;ORAL Discontinued
EQ 105MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription
EQ 115MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription
EQ 135MG BASE TABLET, EXTENDED RELEASE;ORAL Discontinued

5. Drug name - XIMINO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7790705 JOURNEY Minocycline oral dosage forms for the treatment of acne Jun, 2025

(2 years from now)

US8252776 JOURNEY Minocycline oral dosage forms for the treatment of acne Jun, 2025

(2 years from now)

US8268804 JOURNEY Minocycline oral dosage forms for the treatment of acne Jun, 2025

(2 years from now)

US7919483 JOURNEY Method for the treatment of acne Mar, 2027

(4 years from now)

US7544373 JOURNEY Minocycline oral dosage forms for the treatment of acne Apr, 2027

(4 years from now)

US7541347 JOURNEY Minocycline oral dosage forms for the treatment of acne Apr, 2027

(4 years from now)

Treatment: Treatment of acne; Treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 45MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription
EQ 67.5MG BASE CAPSULE, EXTENDED RELEASE;ORAL Discontinued
EQ 90MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription
EQ 112.5MG BASE CAPSULE, EXTENDED RELEASE;ORAL Discontinued
EQ 135MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription

6. Drug name - ZILXI

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10946101 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct, 2030

(7 years from now)

US8945516 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct, 2030

(7 years from now)

US10265404 JOURNEY Compositions, gels and foams with rheology modulators and uses thereof Oct, 2030

(7 years from now)

US10213512 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US8992896 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US9675700 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US8865139 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US10322186 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

Treatment: Treatment of inflammatory lesions of rosacea.

Dosage: AEROSOL, FOAM;TOPICAL

More Information on Dosage
Strength Dosage Availability
EQ 1.5% BASE AEROSOL, FOAM;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.